Financials
Income statement
Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 5.3B | 5.2B | 5.1B | 4.9B |
Cost of revenue | 2.0B | 2.0B | 2.0B | 2.0B |
Gross profit | 3.2B | 3.2B | 3.1B | 2.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.6B | 1.6B | 1.7B | 1.7B |
Other operating expenses | — | — | — | — |
Operating income | 1.7B | 1.6B | 1.4B | 1.2B |
Non operating interest income | ||||
Income | 11M | 13M | 9M | 10M |
Expense | 334M | 339M | 294M | 271M |
Other income expense | -161M | -5M | -5M | -7M |
Pretax income | 1.2B | 1.3B | 1.1B | 913M |
Tax provision | 193M | 74M | 221M | 153M |
Net income | 948M | 571M | 909M | 752M |
Basic EPS | — | 1.0 | 1.5 | 1.2 |
Diluted EPS | — | 1.0 | 1.5 | 1.2 |
Basic average shares | — | 573.7M | 582.7M | 590.9M |
Diluted average shares | — | 576.9M | 585.4M | 594.8M |
EBITDA | 2.3B | 2.4B | 2.2B | 2.0B |
Net income from continuing op. | 948M | 571M | 909M | 752M |
Minority interests | -10M | -7M | -15M | -17M |
Preferred stock dividends | — | — | — | — |